In addition, ALG3 facilitated metastatic potential by inducing the α1,3-mannosylation of uPAR, whereas uPAR N-glycosylation site mutation and the inhibition of α1,3-mannosylation by ALG3 downregulation suppressed ovarian cancer metastasis. This evidence concerns the gene ALG3 and ovarian carcinoma.